Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab

Abstract Background The treatment of Cutaneous Squamous Cell Carcinoma (CSCC) has undergone significant changes with the introduction of Immune Checkpoint Inhibitors (ICIs). While promising results have been observed, their efficacy remains limited to a subset of patients. Soluble immune checkpoint...

Full description

Bibliographic Details

Published in:	Journal of Translational Medicine
Main Authors:	I. Vanni, M. Croce, L. Pastorino, E. Allavena, F. Barbero, S. Coco, S. Santamaria, A. G. Bosio, A. Boutros, A. Rosa, V. Fontana, F. Spagnolo, P. Ghiorzo, E. T. Tanda
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Subjects:	cfDNA PD-L1 LAG-3 TIM-3 CTLA-4 IFN-γ
Online Access:	https://doi.org/10.1186/s12967-025-06957-7